MiR-645 promotes invasiveness, metastasis and tumor growth in colorectal cancer by targeting EFNA5
• MiR-645 promotes CRC cell migration and invasion in vitro and in vivo. • MiR-645 stimulates the EMT of CRC cells. • EFNA5 mRNA is a direct target of miR-645. • MiR-645 expression inversely correlates with EFNA5 expression in clinical CRC specimens.
Gespeichert in:
| Autor*in: |
Li, Shuai [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2020 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a - Liao, Gary ELSEVIER, 2020, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:125 ; year:2020 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.biopha.2020.109889 |
|---|
| Katalog-ID: |
ELV049650904 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV049650904 | ||
| 003 | DE-627 | ||
| 005 | 20230624154802.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200518s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.biopha.2020.109889 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001975.pica |
| 035 | |a (DE-627)ELV049650904 | ||
| 035 | |a (ELSEVIER)S0753-3322(20)30079-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.86 |2 bkl | ||
| 100 | 1 | |a Li, Shuai |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a MiR-645 promotes invasiveness, metastasis and tumor growth in colorectal cancer by targeting EFNA5 |
| 264 | 1 | |c 2020 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • MiR-645 promotes CRC cell migration and invasion in vitro and in vivo. • MiR-645 stimulates the EMT of CRC cells. • EFNA5 mRNA is a direct target of miR-645. • MiR-645 expression inversely correlates with EFNA5 expression in clinical CRC specimens. | ||
| 650 | 7 | |a Cell invasion |2 Elsevier | |
| 650 | 7 | |a MiR-645 |2 Elsevier | |
| 650 | 7 | |a Colorectal cancer |2 Elsevier | |
| 650 | 7 | |a Metastasis |2 Elsevier | |
| 650 | 7 | |a EFNA5 |2 Elsevier | |
| 700 | 1 | |a Hou, Xinfang |4 oth | |
| 700 | 1 | |a Wu, Chen |4 oth | |
| 700 | 1 | |a Han, Lili |4 oth | |
| 700 | 1 | |a Li, Qian |4 oth | |
| 700 | 1 | |a Wang, Jufeng |4 oth | |
| 700 | 1 | |a Luo, Suxia |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Liao, Gary ELSEVIER |t A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a |d 2020 |g Amsterdam [u.a.] |w (DE-627)ELV004620771 |
| 773 | 1 | 8 | |g volume:125 |g year:2020 |g pages:0 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.biopha.2020.109889 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.86 |j Hämatologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 125 |j 2020 |h 0 | ||
| author_variant |
s l sl |
|---|---|
| matchkey_str |
lishuaihouxinfangwuchenhanlililiqianwang:2020----:i65rmtsnaieeseatssntmrrwhnooetl |
| hierarchy_sort_str |
2020 |
| bklnumber |
44.86 |
| publishDate |
2020 |
| allfields |
10.1016/j.biopha.2020.109889 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001975.pica (DE-627)ELV049650904 (ELSEVIER)S0753-3322(20)30079-2 DE-627 ger DE-627 rakwb eng 610 VZ 44.86 bkl Li, Shuai verfasserin aut MiR-645 promotes invasiveness, metastasis and tumor growth in colorectal cancer by targeting EFNA5 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • MiR-645 promotes CRC cell migration and invasion in vitro and in vivo. • MiR-645 stimulates the EMT of CRC cells. • EFNA5 mRNA is a direct target of miR-645. • MiR-645 expression inversely correlates with EFNA5 expression in clinical CRC specimens. Cell invasion Elsevier MiR-645 Elsevier Colorectal cancer Elsevier Metastasis Elsevier EFNA5 Elsevier Hou, Xinfang oth Wu, Chen oth Han, Lili oth Li, Qian oth Wang, Jufeng oth Luo, Suxia oth Enthalten in Elsevier Science Liao, Gary ELSEVIER A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a 2020 Amsterdam [u.a.] (DE-627)ELV004620771 volume:125 year:2020 pages:0 https://doi.org/10.1016/j.biopha.2020.109889 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.86 Hämatologie VZ AR 125 2020 0 |
| spelling |
10.1016/j.biopha.2020.109889 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001975.pica (DE-627)ELV049650904 (ELSEVIER)S0753-3322(20)30079-2 DE-627 ger DE-627 rakwb eng 610 VZ 44.86 bkl Li, Shuai verfasserin aut MiR-645 promotes invasiveness, metastasis and tumor growth in colorectal cancer by targeting EFNA5 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • MiR-645 promotes CRC cell migration and invasion in vitro and in vivo. • MiR-645 stimulates the EMT of CRC cells. • EFNA5 mRNA is a direct target of miR-645. • MiR-645 expression inversely correlates with EFNA5 expression in clinical CRC specimens. Cell invasion Elsevier MiR-645 Elsevier Colorectal cancer Elsevier Metastasis Elsevier EFNA5 Elsevier Hou, Xinfang oth Wu, Chen oth Han, Lili oth Li, Qian oth Wang, Jufeng oth Luo, Suxia oth Enthalten in Elsevier Science Liao, Gary ELSEVIER A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a 2020 Amsterdam [u.a.] (DE-627)ELV004620771 volume:125 year:2020 pages:0 https://doi.org/10.1016/j.biopha.2020.109889 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.86 Hämatologie VZ AR 125 2020 0 |
| allfields_unstemmed |
10.1016/j.biopha.2020.109889 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001975.pica (DE-627)ELV049650904 (ELSEVIER)S0753-3322(20)30079-2 DE-627 ger DE-627 rakwb eng 610 VZ 44.86 bkl Li, Shuai verfasserin aut MiR-645 promotes invasiveness, metastasis and tumor growth in colorectal cancer by targeting EFNA5 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • MiR-645 promotes CRC cell migration and invasion in vitro and in vivo. • MiR-645 stimulates the EMT of CRC cells. • EFNA5 mRNA is a direct target of miR-645. • MiR-645 expression inversely correlates with EFNA5 expression in clinical CRC specimens. Cell invasion Elsevier MiR-645 Elsevier Colorectal cancer Elsevier Metastasis Elsevier EFNA5 Elsevier Hou, Xinfang oth Wu, Chen oth Han, Lili oth Li, Qian oth Wang, Jufeng oth Luo, Suxia oth Enthalten in Elsevier Science Liao, Gary ELSEVIER A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a 2020 Amsterdam [u.a.] (DE-627)ELV004620771 volume:125 year:2020 pages:0 https://doi.org/10.1016/j.biopha.2020.109889 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.86 Hämatologie VZ AR 125 2020 0 |
| allfieldsGer |
10.1016/j.biopha.2020.109889 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001975.pica (DE-627)ELV049650904 (ELSEVIER)S0753-3322(20)30079-2 DE-627 ger DE-627 rakwb eng 610 VZ 44.86 bkl Li, Shuai verfasserin aut MiR-645 promotes invasiveness, metastasis and tumor growth in colorectal cancer by targeting EFNA5 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • MiR-645 promotes CRC cell migration and invasion in vitro and in vivo. • MiR-645 stimulates the EMT of CRC cells. • EFNA5 mRNA is a direct target of miR-645. • MiR-645 expression inversely correlates with EFNA5 expression in clinical CRC specimens. Cell invasion Elsevier MiR-645 Elsevier Colorectal cancer Elsevier Metastasis Elsevier EFNA5 Elsevier Hou, Xinfang oth Wu, Chen oth Han, Lili oth Li, Qian oth Wang, Jufeng oth Luo, Suxia oth Enthalten in Elsevier Science Liao, Gary ELSEVIER A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a 2020 Amsterdam [u.a.] (DE-627)ELV004620771 volume:125 year:2020 pages:0 https://doi.org/10.1016/j.biopha.2020.109889 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.86 Hämatologie VZ AR 125 2020 0 |
| allfieldsSound |
10.1016/j.biopha.2020.109889 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001975.pica (DE-627)ELV049650904 (ELSEVIER)S0753-3322(20)30079-2 DE-627 ger DE-627 rakwb eng 610 VZ 44.86 bkl Li, Shuai verfasserin aut MiR-645 promotes invasiveness, metastasis and tumor growth in colorectal cancer by targeting EFNA5 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • MiR-645 promotes CRC cell migration and invasion in vitro and in vivo. • MiR-645 stimulates the EMT of CRC cells. • EFNA5 mRNA is a direct target of miR-645. • MiR-645 expression inversely correlates with EFNA5 expression in clinical CRC specimens. Cell invasion Elsevier MiR-645 Elsevier Colorectal cancer Elsevier Metastasis Elsevier EFNA5 Elsevier Hou, Xinfang oth Wu, Chen oth Han, Lili oth Li, Qian oth Wang, Jufeng oth Luo, Suxia oth Enthalten in Elsevier Science Liao, Gary ELSEVIER A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a 2020 Amsterdam [u.a.] (DE-627)ELV004620771 volume:125 year:2020 pages:0 https://doi.org/10.1016/j.biopha.2020.109889 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.86 Hämatologie VZ AR 125 2020 0 |
| language |
English |
| source |
Enthalten in A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a Amsterdam [u.a.] volume:125 year:2020 pages:0 |
| sourceStr |
Enthalten in A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a Amsterdam [u.a.] volume:125 year:2020 pages:0 |
| format_phy_str_mv |
Article |
| bklname |
Hämatologie |
| institution |
findex.gbv.de |
| topic_facet |
Cell invasion MiR-645 Colorectal cancer Metastasis EFNA5 |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a |
| authorswithroles_txt_mv |
Li, Shuai @@aut@@ Hou, Xinfang @@oth@@ Wu, Chen @@oth@@ Han, Lili @@oth@@ Li, Qian @@oth@@ Wang, Jufeng @@oth@@ Luo, Suxia @@oth@@ |
| publishDateDaySort_date |
2020-01-01T00:00:00Z |
| hierarchy_top_id |
ELV004620771 |
| dewey-sort |
3610 |
| id |
ELV049650904 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV049650904</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624154802.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200518s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.biopha.2020.109889</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001975.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV049650904</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0753-3322(20)30079-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.86</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Li, Shuai</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">MiR-645 promotes invasiveness, metastasis and tumor growth in colorectal cancer by targeting EFNA5</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• MiR-645 promotes CRC cell migration and invasion in vitro and in vivo. • MiR-645 stimulates the EMT of CRC cells. • EFNA5 mRNA is a direct target of miR-645. • MiR-645 expression inversely correlates with EFNA5 expression in clinical CRC specimens.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cell invasion</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MiR-645</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Colorectal cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Metastasis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EFNA5</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hou, Xinfang</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wu, Chen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Han, Lili</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Qian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Jufeng</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Luo, Suxia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Liao, Gary ELSEVIER</subfield><subfield code="t">A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a</subfield><subfield code="d">2020</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV004620771</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:125</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.biopha.2020.109889</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.86</subfield><subfield code="j">Hämatologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">125</subfield><subfield code="j">2020</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| author |
Li, Shuai |
| spellingShingle |
Li, Shuai ddc 610 bkl 44.86 Elsevier Cell invasion Elsevier MiR-645 Elsevier Colorectal cancer Elsevier Metastasis Elsevier EFNA5 MiR-645 promotes invasiveness, metastasis and tumor growth in colorectal cancer by targeting EFNA5 |
| authorStr |
Li, Shuai |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV004620771 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.86 bkl MiR-645 promotes invasiveness, metastasis and tumor growth in colorectal cancer by targeting EFNA5 Cell invasion Elsevier MiR-645 Elsevier Colorectal cancer Elsevier Metastasis Elsevier EFNA5 Elsevier |
| topic |
ddc 610 bkl 44.86 Elsevier Cell invasion Elsevier MiR-645 Elsevier Colorectal cancer Elsevier Metastasis Elsevier EFNA5 |
| topic_unstemmed |
ddc 610 bkl 44.86 Elsevier Cell invasion Elsevier MiR-645 Elsevier Colorectal cancer Elsevier Metastasis Elsevier EFNA5 |
| topic_browse |
ddc 610 bkl 44.86 Elsevier Cell invasion Elsevier MiR-645 Elsevier Colorectal cancer Elsevier Metastasis Elsevier EFNA5 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
x h xh c w cw l h lh q l ql j w jw s l sl |
| hierarchy_parent_title |
A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a |
| hierarchy_parent_id |
ELV004620771 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV004620771 |
| title |
MiR-645 promotes invasiveness, metastasis and tumor growth in colorectal cancer by targeting EFNA5 |
| ctrlnum |
(DE-627)ELV049650904 (ELSEVIER)S0753-3322(20)30079-2 |
| title_full |
MiR-645 promotes invasiveness, metastasis and tumor growth in colorectal cancer by targeting EFNA5 |
| author_sort |
Li, Shuai |
| journal |
A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a |
| journalStr |
A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2020 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Li, Shuai |
| container_volume |
125 |
| class |
610 VZ 44.86 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Li, Shuai |
| doi_str_mv |
10.1016/j.biopha.2020.109889 |
| dewey-full |
610 |
| title_sort |
mir-645 promotes invasiveness, metastasis and tumor growth in colorectal cancer by targeting efna5 |
| title_auth |
MiR-645 promotes invasiveness, metastasis and tumor growth in colorectal cancer by targeting EFNA5 |
| abstract |
• MiR-645 promotes CRC cell migration and invasion in vitro and in vivo. • MiR-645 stimulates the EMT of CRC cells. • EFNA5 mRNA is a direct target of miR-645. • MiR-645 expression inversely correlates with EFNA5 expression in clinical CRC specimens. |
| abstractGer |
• MiR-645 promotes CRC cell migration and invasion in vitro and in vivo. • MiR-645 stimulates the EMT of CRC cells. • EFNA5 mRNA is a direct target of miR-645. • MiR-645 expression inversely correlates with EFNA5 expression in clinical CRC specimens. |
| abstract_unstemmed |
• MiR-645 promotes CRC cell migration and invasion in vitro and in vivo. • MiR-645 stimulates the EMT of CRC cells. • EFNA5 mRNA is a direct target of miR-645. • MiR-645 expression inversely correlates with EFNA5 expression in clinical CRC specimens. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
MiR-645 promotes invasiveness, metastasis and tumor growth in colorectal cancer by targeting EFNA5 |
| url |
https://doi.org/10.1016/j.biopha.2020.109889 |
| remote_bool |
true |
| author2 |
Hou, Xinfang Wu, Chen Han, Lili Li, Qian Wang, Jufeng Luo, Suxia |
| author2Str |
Hou, Xinfang Wu, Chen Han, Lili Li, Qian Wang, Jufeng Luo, Suxia |
| ppnlink |
ELV004620771 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth |
| doi_str |
10.1016/j.biopha.2020.109889 |
| up_date |
2024-07-06T22:10:21.147Z |
| _version_ |
1803869299564085248 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV049650904</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624154802.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200518s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.biopha.2020.109889</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001975.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV049650904</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0753-3322(20)30079-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.86</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Li, Shuai</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">MiR-645 promotes invasiveness, metastasis and tumor growth in colorectal cancer by targeting EFNA5</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• MiR-645 promotes CRC cell migration and invasion in vitro and in vivo. • MiR-645 stimulates the EMT of CRC cells. • EFNA5 mRNA is a direct target of miR-645. • MiR-645 expression inversely correlates with EFNA5 expression in clinical CRC specimens.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cell invasion</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MiR-645</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Colorectal cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Metastasis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EFNA5</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hou, Xinfang</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wu, Chen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Han, Lili</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Qian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Jufeng</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Luo, Suxia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Liao, Gary ELSEVIER</subfield><subfield code="t">A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a</subfield><subfield code="d">2020</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV004620771</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:125</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.biopha.2020.109889</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.86</subfield><subfield code="j">Hämatologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">125</subfield><subfield code="j">2020</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.3997946 |